Education
About Us
Working with TipRanks
Follow Us
Lipella Pharmaceuticals, Inc. (LIPO)
NASDAQ:LIPO
RESEARCH TOOLSreports
Total Valuation
Lipella Pharmaceuticals, Inc. has a market cap or net worth of $5.81M. The enterprise value is ―.
Market Cap$5.81M
Enterprise Value―
Share Statistics
Lipella Pharmaceuticals, Inc. has 2,548,811 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,548,811
Owned by Insiders44.87%
Owned by Institutions0.52%
Financial Efficiency
Lipella Pharmaceuticals, Inc.’s return on equity (ROE) is -2.61 and return on invested capital (ROIC) is -258.28%.
Return on Equity (ROE)-2.61
Return on Assets (ROA)-1.88
Return on Invested Capital (ROIC)-258.28%
Return on Capital Employed (ROCE)-2.65
Revenue Per Employee107.27M
Profits Per Employee-1.00B
Employee Count5
Asset Turnover0.20
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lipella Pharmaceuticals, Inc. is >-0.01. Lipella Pharmaceuticals, Inc.’s PEG ratio is >-0.01.
PE Ratio>-0.01
PS Ratio6.48
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio>-0.01
Income Statement
In the last 12 months, Lipella Pharmaceuticals, Inc. had revenue of 536.36M and earned -5.02B in profits. Earnings per share was -4.79K.
Revenue536.36M
Gross Profit536.36M
Operating Income-5.08B
Pretax Income-5.02B
Net Income-5.02B
EBITDA-5.08B
Earnings Per Share (EPS)-4.79K
Cash Flow
In the last 12 months, operating cash flow was -3.69M and capital expenditures -14.42M, giving a free cash flow of -18.11M billion.
Operating Cash Flow-3.69M
Free Cash Flow-18.11M
Free Cash Flow per Share-7.11
Dividends & Yields
Lipella Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.11
52-Week Price Change-57.89%
50-Day Moving Average2.72
200-Day Moving Average3.20
Relative Strength Index (RSI)46.70
Average Volume (3m)39.23K
Important Dates
Lipella Pharmaceuticals, Inc. upcoming earnings date is May 15, 2023, TBA Not Confirmed.
Last Earnings DateMar 31, 2023
Next Earnings DateMay 15, 2023
Ex-Dividend Date―
Financial Position
Lipella Pharmaceuticals, Inc. as a current ratio of 3.47, with Debt / Equity ratio of 4.85%
Current Ratio3.47
Quick Ratio3.47
Debt to Market Cap14.89
Net Debt to EBITDA0.42
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Lipella Pharmaceuticals, Inc. has paid -5.02B in taxes.
Income Tax-5.02B
Effective Tax Rate0.00
Enterprise Valuation
Lipella Pharmaceuticals, Inc. EV to EBITDA ratio is 0.42, with an EV/FCF ratio of 0.54.
EV to Sales-3.98
EV to EBITDA0.42
EV to Free Cash Flow0.54
EV to Operating Cash Flow0.54
Balance Sheet
Lipella Pharmaceuticals, Inc. has $1.35M in cash and marketable securities with $115.70K in debt, giving a net cash position of -$1.28M billion.
Cash & Marketable Securities$1.35M
Total Debt$115.70K
Net Cash-$1.28M
Net Cash Per Share-$0.50
Tangible Book Value Per Share$1.83K
Margins
Gross margin is 98.75%, with operating margin of -947.23%, and net profit margin of -935.25%.
Gross Margin98.75%
Operating Margin-947.23%
Pretax Margin-935.25%
Net Profit Margin-935.25%
EBITDA Margin-947.23%
EBIT Margin0.00%
Analyst Forecast
The average price target for Lipella Pharmaceuticals, Inc. is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside338.60% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―